Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gilson

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With MenAllen Lin, Koh J Ong, Peter Hobbelen, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2007
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivityHelen Cooksley, Shilpa Chokshi, Yafit Maayan, et al.
BMJ (Clinical Research Ed.)|March 8, 2005
Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort studyCaroline A Sabin, Teresa Hill, Fiona Lampe, et al.
AIDS (London, England)|March 4, 2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapySophie Jose, Killian Quinn, Teresa Hill, et al.
The Lancet. Public Health|September 5, 2020
Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective studyNadia Hanum, Valentina Cambiano, Janey Sewell, et al.
AIDS and Behavior|September 3, 2016
Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UKMarina Daskalopoulou, Fiona C Lampe, Lorraine Sherr, et al.
Cell Reports|July 26, 2016
Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same HostAnna Schurich, Laura J Pallett, Danyal Jajbhay, et al.
BMJ Public Health|March 11, 2026
Prevalence and factors associated with use of prophylaxis for HIV and sexually transmitted infections among sexual health service attendees in England: findings from a cross-sectional observational studyJames Bell, Manik Kohli, Caisey Pulford, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3Kholoud Porter, Sarah Walker, Teresa Hill, et al.
HIV Medicine|September 5, 2023
Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohortAlejandro Arenas-Pinto, Nicholas Bakewell, Ana Milinkovic, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With MenAllen Lin, Koh J Ong, Peter Hobbelen, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2007
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivityHelen Cooksley, Shilpa Chokshi, Yafit Maayan, et al.
BMJ (Clinical Research Ed.)|March 8, 2005
Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort studyCaroline A Sabin, Teresa Hill, Fiona Lampe, et al.
AIDS (London, England)|March 4, 2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapySophie Jose, Killian Quinn, Teresa Hill, et al.
The Lancet. Public Health|September 5, 2020
Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective studyNadia Hanum, Valentina Cambiano, Janey Sewell, et al.
AIDS and Behavior|September 3, 2016
Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UKMarina Daskalopoulou, Fiona C Lampe, Lorraine Sherr, et al.
Cell Reports|July 26, 2016
Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same HostAnna Schurich, Laura J Pallett, Danyal Jajbhay, et al.
BMJ Public Health|March 11, 2026
Prevalence and factors associated with use of prophylaxis for HIV and sexually transmitted infections among sexual health service attendees in England: findings from a cross-sectional observational studyJames Bell, Manik Kohli, Caisey Pulford, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3Kholoud Porter, Sarah Walker, Teresa Hill, et al.
HIV Medicine|September 5, 2023
Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohortAlejandro Arenas-Pinto, Nicholas Bakewell, Ana Milinkovic, et al.
Pageof 15